Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications

Introduction: There have been concerns with the availability and affordability of EMA’s recently approved medicines with a conditional approval in Korea. This needs to be addressed to provide future guidance to the authorities in Korea. Objective: Compare the availability and affordability of medici...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hye-Young, Kim, Hyungmin, Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129763/
https://www.ncbi.nlm.nih.gov/pubmed/30233363
http://dx.doi.org/10.3389/fphar.2018.00938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129763/
https://www.ncbi.nlm.nih.gov/pubmed/30233363
http://dx.doi.org/10.3389/fphar.2018.00938

Ejemplares similares